Dr. Eric Goosby: The M72 vaccine could be a breakthrough. “It is a moment.”

The CommonHealth

A tartalmat a CSIS Global Health Policy Center | Center for Strategic and International Studies, CSIS Global Health Policy Center | Center for Strategic, and International Studies biztosítja. Az összes podcast-tartalmat, beleértve az epizódokat, grafikákat és podcast-leírásokat, közvetlenül a CSIS Global Health Policy Center | Center for Strategic and International Studies, CSIS Global Health Policy Center | Center for Strategic, and International Studies vagy a podcast platform partnere tölti fel és biztosítja. Ha úgy gondolja, hogy valaki az Ön engedélye nélkül használja fel a szerzői joggal védett művét, kövesse az itt leírt folyamatot https://hu.player.fm/legal.

11M ago 28:38

MP3•Epizód kép

Dr. Eric Goosby walks us through the Lancet Commission report on tuberculosis—which he chaired—that was issued immediately prior to the September 22 UN High Level Meeting on TB. The environment for progress remains very tough—shortfalls in political will, prioritization, finances, and investment by industry. But there are recent, promising gains in diagnostics and therapies. And a promising vaccine, M72, is now in advanced trials. That could be a breakthrough in the future. GSK, in partnership with Gates Foundation and Wellcome Trust, are investing $550m in fields trials across Africa and Southeast Asia. What was the significance of the High-Level Meeting? It generated a detailed agenda to which national governments should be held to account. Eric closes with personal reflections on the passing of Senator Dianne Feinstein.

270 epizódok

#Fitness #Non-Profit #Business #News #Government #CSIS Global Health Policy Center | Center for Strategic #International Studies